Neurologist, Mayo Clinic
April 16, 2021
Video
The neurologist from Mayo Clinic discussed his abstract at AAN 2021 comparing stroke rates in patients with cerebral amyloid antipathy given treatment with aspirin.
Cognitive Functioning and Motor Difficulties Identified in Spinal Muscular Atrophy Type 3
Background Factors Drive Elevated Risk of Neonatal Seizures, Epilepsy in Children of Mothers on SSRI/SNRIs
Advocacy’s Part in the Progress in ALS: Matthew B. Harms, MD
This Week on NeurologyLive® — May 16, 2022